Cambridge, UK, 17th January 2019: A great opportunity has arisen to meet PredictImmune’s VP of Platform Discovery, Dr Paul Lyons, and discuss the latest data on its new prognostic biomarker test, PredictSURE® IBD. Both Dr Lyons and Dr Karen Hills will be on booth #1406 of the Crohn’s and Colitis Foundation Congress, Bellagio Conference Centre, Las Vegas, Feb 7th through 9th. Join them to hear the latest developments and discuss availability of the test in the US.
Crohn’s and Colitis Congress, February 7-9th 2019
Venue: Bellagio Conference Centre, Las Vegas, NV
The congress, the premier US conference on IBD, offers a great opportunity to gain a multidisciplinary perspective on treating inflammatory bowel diseases (IBD). The congress will allow you to mix with fellow healthcare professionals and researchers, discover the latest research, and gain different perspectives on IBD treatment. Furthermore, it’s an excellent opportunity to hear about ground-breaking developments such as the PredictSURE® IBD prognostic test.
The PredictImmune team look forward to meeting you at stand #86 in the Exhibition area.